Comparing the effects of different cell death programs in tumor progression and immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparing the effects of different cell death programs in tumor progression and immunotherapy
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume 26, Issue 1, Pages 115-129
Publisher
Springer Nature
Online
2018-10-19
DOI
10.1038/s41418-018-0214-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells
- (2018) Lin Jing et al. CANCER LETTERS
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Low Necroptosis Process Predicts Poor Treatment Outcome of Human Papillomavirus Positive Cervical Cancers by Decreasing Tumor-Associated Macrophages M1 Polarization
- (2018) Lin Li et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
- (2018) Tuo Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review: Cell Death, Nucleic Acids, and Immunity
- (2018) Keith B. Elkon Arthritis & Rheumatology
- Exploitation of Apoptotic Regulation in Cancer
- (2018) David S. Ucker et al. Frontiers in Immunology
- Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
- (2018) Joe Abdo et al. Frontiers in Oncology
- Death begets a new beginning
- (2017) Lidia Bosurgi et al. IMMUNOLOGICAL REVIEWS
- Necroptotic cell death in anti-cancer therapy
- (2017) Olga Krysko et al. IMMUNOLOGICAL REVIEWS
- The in vivo evidence for regulated necrosis
- (2017) Wulf Tonnus et al. IMMUNOLOGICAL REVIEWS
- RIPK3-driven cell death during virus infections
- (2017) Jason W. Upton et al. IMMUNOLOGICAL REVIEWS
- Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment
- (2017) Sushil Kumar et al. IMMUNOLOGICAL REVIEWS
- Relevance of necroptosis in cancer
- (2017) Najoua Lalaoui et al. IMMUNOLOGY AND CELL BIOLOGY
- PD-L1
- (2017) Anthousa Kythreotou et al. JOURNAL OF CLINICAL PATHOLOGY
- Regression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice
- (2017) Gui-Wei He et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective
- (2017) Deepak Bhattarai et al. MEDICINAL RESEARCH REVIEWS
- Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency
- (2017) Evangelos Giampazolias et al. NATURE CELL BIOLOGY
- Is autoimmunity the Achilles' heel of cancer immunotherapy?
- (2017) Carl H June et al. NATURE MEDICINE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
- (2017) Jianjin Shi et al. TRENDS IN BIOCHEMICAL SCIENCES
- Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection
- (2017) Megan H. Orzalli et al. TRENDS IN CELL BIOLOGY
- Necroptosis in cancer: An angel or a demon?
- (2017) Tianzhen Wang et al. TUMOR BIOLOGY
- Recognizing and managing on toxicities in cancer immunotherapy
- (2017) Liu Yang et al. TUMOR BIOLOGY
- RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function
- (2017) Kay Hänggi et al. Cell Death & Disease
- Exploitation of necroptosis for treatment of caspase-compromised cancers
- (2017) Young Sik Cho et al. Oncology Letters
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Caspase Inhibition Prevents Tumor Necrosis Factor-α–Induced Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes in Vivo and in Vitro
- (2016) Hong-Min Ni et al. AMERICAN JOURNAL OF PATHOLOGY
- RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
- (2016) Ulrike Höckendorf et al. CANCER CELL
- Role of the tumor microenvironment in regulating apoptosis and cancer progression
- (2016) Katherine Yaacoub et al. CANCER LETTERS
- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
- (2016) Henrique Lemos et al. CANCER RESEARCH
- Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
- (2016) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death
- (2016) Roshan J. Thapa et al. Cell Host & Microbe
- An outline of necrosome triggers
- (2016) Tom Vanden Berghe et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Biomarkers for the detection of necroptosis
- (2016) Sudan He et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular Pathways: The Necrosome—A Target for Cancer Therapy
- (2016) Lena Seifert et al. CLINICAL CANCER RESEARCH
- Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways
- (2016) Adeeb Derakhshan et al. CLINICAL CANCER RESEARCH
- The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis
- (2016) Silvia Alvarez-Diaz et al. IMMUNITY
- RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
- (2016) Malek Najjar et al. IMMUNITY
- Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate
- (2016) Michelle A. Hughes et al. MOLECULAR CELL
- The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
- (2016) Lena Seifert et al. NATURE
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Ionic immune suppression within the tumour microenvironment limits T cell effector function
- (2016) Robert Eil et al. NATURE
- IAP antagonists induce anti-tumor immunity in multiple myeloma
- (2016) Marta Chesi et al. NATURE MEDICINE
- Necroptosis in development, inflammation and disease
- (2016) Ricardo Weinlich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Programmed necrosis in inflammation: Toward identification of the effector molecules
- (2016) D. Wallach et al. SCIENCE
- More to Life than NF-κB in TNFR1 Signaling
- (2016) Adrian T. Ting et al. TRENDS IN IMMUNOLOGY
- Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis
- (2016) Dominique Bozec et al. Oncotarget
- Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
- (2016) Heng Yang et al. OncoImmunology
- Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation
- (2016) Lindsey M. Ludwig et al. Frontiers in Pediatrics
- Mitochondrial apoptosis: killing cancer using the enemy within
- (2015) J Lopez et al. BRITISH JOURNAL OF CANCER
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
- (2015) Gi-Bang Koo et al. CELL RESEARCH
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- RIPK1 and NF- B signaling in dying cells determines cross-priming of CD8+ T cells
- (2015) N. Yatim et al. SCIENCE
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
- (2015) K Moriwaki et al. Cell Death & Disease
- Tumor-intrinsic oncogene pathways mediating immune avoidance
- (2015) Stefani Spranger et al. OncoImmunology
- Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
- (2014) Michael J. White et al. CELL
- Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
- (2014) Anthony Rongvaux et al. CELL
- The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade
- (2014) A. Ribas et al. CLINICAL CANCER RESEARCH
- Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment
- (2014) Vinit Kumar et al. IMMUNOLOGY
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells
- (2014) Yang Xu et al. PLoS One
- Necroptosis, in vivo detection in experimental disease models
- (2014) Sandrine Jouan-Lanhouet et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Therapeutic exploitation of necroptosis for cancer therapy
- (2014) Simone Fulda SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
- (2014) K E McCabe et al. Cell Death & Disease
- Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
- (2013) Jianfeng Wu et al. CELL RESEARCH
- Short-Term Intratumoral Interleukin-12 Expressed from an Alphaviral Vector Is Sufficient to Induce an Efficient Antitumoral Response Against Spontaneous Hepatocellular Carcinomas
- (2013) Juan R. Rodriguez-Madoz et al. HUMAN GENE THERAPY
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
- (2013) James M. Murphy et al. IMMUNITY
- Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
- (2013) William J. Kaiser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model
- (2013) Carina Riediger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
- (2013) Mayur V. Jain et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1
- (2013) Chuanjiang Huang et al. PLoS One
- Apoptosome Structure, Assembly, and Procaspase Activation
- (2013) Shujun Yuan et al. STRUCTURE
- Evading apoptosis in cancer
- (2013) Kaleigh Fernald et al. TRENDS IN CELL BIOLOGY
- Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis
- (2013) L Steinhart et al. Cell Death & Disease
- The ‘complexities’ of life and death: Death receptor signalling platforms
- (2012) Laura S. Dickens et al. EXPERIMENTAL CELL RESEARCH
- Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions
- (2012) Selcen Öztürk et al. EXPERIMENTAL CELL RESEARCH
- Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation
- (2012) James E. Vince et al. IMMUNITY
- F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells
- (2012) Susan Ahrens et al. IMMUNITY
- EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model
- (2012) Manish Tandon et al. JOURNAL OF GENE MEDICINE
- Unknown
- (2012) Hulda Hreggvidsdottir et al. MOLECULAR MEDICINE
- Activation of P2X7 Receptor by ATP Plays an Important Role in Regulating Inflammatory Responses during Acute Viral Infection
- (2012) Benjamin H. Lee et al. PLoS One
- ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation
- (2012) N Riteau et al. Cell Death & Disease
- Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
- (2011) Abhishek D. Garg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review
- (2011) Colin H Richards et al. Future Oncology
- RIP3 mediates the embryonic lethality of caspase-8-deficient mice
- (2011) William J. Kaiser et al. NATURE
- Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
- (2011) Andrew Oberst et al. NATURE
- Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway
- (2011) S. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Caspase-8 as a therapeutic target in cancer
- (2010) Dwayne G. Stupack CANCER LETTERS
- Autoimmunity and the Clearance of Dead Cells
- (2010) Shigekazu Nagata et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Virus Inhibition of RIP3-Dependent Necrosis
- (2010) Jason W. Upton et al. Cell Host & Microbe
- Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation
- (2010) V. Labi et al. GENES & DEVELOPMENT
- Apoptosis-promoted tumorigenesis: -irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death
- (2010) E. M. Michalak et al. GENES & DEVELOPMENT
- Combination of human tumor necrosis factor-alpha (hTNF-α) gene delivery with gemcitabine is effective in models of pancreatic cancer
- (2009) S R Murugesan et al. CANCER GENE THERAPY
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- XIAP discriminates between type I and type II FAS-induced apoptosis
- (2009) Philipp J. Jost et al. NATURE
- Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
- (2009) David Sancho et al. NATURE
- Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia
- (2009) Elli Papaemmanuil et al. NATURE GENETICS
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2-Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy
- (2009) A. B. del Campo et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Naturally-occurring shikonin analogues – A class of necroptotic inducers that circumvent cancer drug resistance
- (2008) Yanyan Xuan et al. CANCER LETTERS
- Apoptosis: controlled demolition at the cellular level
- (2007) Rebecca C. Taylor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now